© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
Reviewing Data on Lenvatinib plus Pembrolizumab Combination Treatment for Advanced Renal Cell Carcinoma - Episode 23
A physician explains why he doesn’t believe there is a “typical” patient and why advanced RCC therapies must be tailored to each case.